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Abstract
Natural products provide many bioactive lead molecules for the discovery of
new medicines. Naturally, derived phytochemicals have exhibited tremendous
biological activities including anticancer activity. More than 60% of antitumor
medicines are closely associated with natural products. In the present study, hexane,
chloroform, acetone and methanol extracts from roots of Moringa peregrina were
screened for phytochemical analysis and anticancer activity. Phytochemical
analysis was performed by Gas Chromatography and Mass spectrometry (GC-MS).
The anticancer potential of the extracts was done on the human breast cancer cell
line (MCF-7) and cell viability was measured using WST-1 Cell Proliferation Assay
Kit. The cell line was treated with different concentrations (10, 20, 40, 80, 160 and
320 µg/ml) of plant extracts and the results were compared with the standard drug
Doxorubicin. The results of GC-MS analysis of different extracts revealed the
presence various compounds. The anticancer studies revealed that the chloroform
extract of M. peregrina have good activity against the human breast cancer cell line
with the IC50 value of 127.38 µg/ml. The IC50 values of hexane, acetone and
methanol extracts were 315.0, 284.8 and 353.10 µg/ml respectively. Whereas the
IC50 value of the standard drug, Doxorubicin was 25.88 µg/ml. Based on these
results, further study is warranted for the isolation of anticancer molecule from
chloroform extract of M. peregrina root tubers.

Keywords: Natural products, Moringa peregrina, phytochemical analysis, GC-MS,
anticancer activity, human breast cancer.
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)Title and Abstract (in Arabic

ﺗﻘﯿﯿﻢ اﻟﺘﺮﻛﯿﺐ اﻟﻜﯿﻤﯿﺎﺋﻲ ﻟﻤﺴﺘﺨﻠﺼﺎت ﺟﺬور اﻟﻤﻮرﯾﻨﻐﺎ )Moringa peregrina (Forssk.
 Fioriواﺣﺘﻤﺎﻟﯿﺔ اﻟﻘﺪرة ﻋﻠﻰ ﻣﻜﺎﻓﺤﺔ اﻟﺴﺮطﺎن

اﻟﻤﻠﺨﺺ
ﺗﻮﻓﺮ اﻟﻤﻨﺘﺠﺎت اﻟﻄﺒﯿﻌﯿﺔ اﻟﻌﺪﯾﺪ ﻣﻦ اﻟﻤﺮﻛﺒﺎت اﻟﺤﯿﻮﯾﺔ اﻟﺘﻲ ﺗﺆدي اﻟﻰ اﻛﺘﺸﺎف أدوﯾﺔ ﺟﺪﯾﺪة .وﺑﻄﺒﯿﻌﺔ
اﻟﺤﺎل ،أظﮭﺮت اﻟﻤﺮﻛﺒﺎت اﻟﻜﯿﻤﯿﺎﺋﯿﺔ اﻟﻨﺒﺎﺗﯿﺔ اﻟﻤﺸﺘﻘﺔ ﻣﻦ ﻣﻨﺘﺠﺎت طﺒﯿﻌﯿﺔ ﻋﻠﻰ ﻓﺎﻋﻠﯿﺘﮭﺎ اﻟﮭﺎﺋﻠﺔ ﻓﻲ اﻻﻧﺸﻄﺔ
اﻟﺒﯿﻮﻟﻮﺟﯿﺔ ﻛﻌﻤﻠﮭﺎ ﻛﻤﻀﺎدات ﻟﻤﺮض اﻟﺴﺮطﺎن .ﺗﺮﺗﺒﻂ أﻛﺜﺮ ﻣﻦ  ٪ 60ﻣﻦ اﻷدوﯾﺔ اﻟﻤﻀﺎدة ﻟﻸورام ﺑﺸﻜﻞ وﺛﯿﻖ
ﻣﻊ اﻟﻤﻨﺘﺠﺎت اﻟﻄﺒﯿﻌﯿﺔ .ﻓﻲ ھﺬه اﻟﺪراﺳﺔ ،ﺗﻢ ﺗﻘﯿﯿﻢ اﻟﻤﺮﻛﺒﺎت اﻟﻜﯿﻤﯿﺎﺋﯿﺔ اﻟﻨﺒﺎﺗﯿﺔ وﻓﺎﻋﻠﯿﺘﮭﺎ ﻓﻲ ﻣﻜﺎﻓﺤﺔ اﻟﺴﺮطﺎن
اﻟﻤﺴﺘﺨﻠﺼﺔ ﻣﻦ ﺟﺬور ﻧﺒﺎت اﻟﻤﻮرﯾﻨﺠﺎ ﺑﻮاﺳﻄﺔ ﻣﺬﯾﺒﺎت ﻣﺨﺘﻠﻔﺔ ﻣﺜﻞ اﻟﮭﻜﺴﺎن واﻟﻜﻠﻮروﻓﻮرم واﻷﺳﯿﺘﻮن
واﻟﻤﯿﺜﺎﻧﻮل.
ﺗﻢ إﺟﺮاء اﻟﺘﺤﻠﯿﻞ اﻟﻜﯿﻤﯿﺎﺋﻲ اﻟﻨﺒﺎﺗﻲ ﺑﻮاﺳﻄﺔ اﻟﺘﺤﻠﯿﻞ اﻟﻜﺮوﻣﺎﺗﻮﺟﺮاﻓﻲ واﻟﻄﯿﻒ اﻟﻜﺘﻠﻲ ) .(GC-MSﺗﻢ
ﺗﻘﯿﯿﻢ ﻗﺪرة اﻟﻤﺴﺘﺨﻠﺼﺎت اﻟﻤﻀﺎدة ﻟﻠﺴﺮطﺎن ﻋﻠﻰ ﺧﻼﯾﺎ ﺳﺮطﺎن اﻟﺜﺪي ) (MCF-7وﺗﻢ ﻗﯿﺎس ﻗﺎﺑﻠﯿﺔ ﺣﯿﻮﯾﺔ اﻟﺨﻠﯿﺔ
ﺑﺎﺳﺘﺨﺪام  .WST-1 Cell Proliferation Assay Kitﺗﻢ ﻣﻌﺎﻣﻠﺔ اﻟﺨﻠﯿﺔ اﻟﻤﺼﺎﺑﺔ ﺑﺎﻟﺴﺮطﺎن ﺑﺘﺮﻛﯿﺰات ﻣﺨﺘﻠﻔﺔ
) 160 ، 80 ، 40 ، 20 ، 10و  320ﻣﯿﻜﺮوﻏﺮام  /ﻣﻞ( ﻣﻦ اﻟﻤﺴﺘﺨﻠﺼﺎت اﻟﻨﺒﺎﺗﯿﺔ وﺗﻤﺖ ﻣﻘﺎرﻧﺔ اﻟﻨﺘﺎﺋﺞ ﻣﻊ
ﻋﻘﺎر دوﻛﺴﻮروﺑﯿﺴﯿﻦ اﻟﻘﯿﺎﺳﻲ.
ﻛﺸﻔﺖ ﻧﺘﺎﺋﺞ ﺗﺤﻠﯿﻞ  GC-MSﻟﻠﻤﺴﺘﺨﻠﺼﺎت اﻟﻤﺨﺘﻠﻔﺔ ﻋﻠﻰ وﺟﻮد ﻋﺪة ﻣﺮﻛﺒﺎت .ﺑﯿﻨﺖ اﻟﺪراﺳﺎت
اﻟﻤﻀﺎدة ﻟﻠﺴﺮطﺎن أن ﻣﺴﺘﺨﻠﺺ اﻟﻜﻠﻮروﻓﻮرم ﻟﮫ ﻧﺸﺎط ﺟﯿﺪ ﺿﺪ ﺧﻼﯾﺎ ﺳﺮطﺎن اﻟﺜﺪي اﻟﺒﺸﺮي ﺑﻘﯿﻤﺔ  IC50اﻟﺒﺎﻟﻐﺔ
 127.38ﻣﯿﻜﺮوﻏﺮام  /ﻣﻞ .ﻛﺎﻧﺖ ﻗﯿﻢ  IC50ﻟﻤﺴﺘﺨﻠﺼﺎت اﻟﮭﻜﺴﺎن واﻷﺳﯿﺘﻮن واﻟﻤﯿﺜﺎﻧﻮل  315.0و  284.8و
 353.10ﻣﯿﻜﺮوﻏﺮام  /ﻣﻞ ﻋﻠﻰ اﻟﺘﻮاﻟﻲ .ﻓﻲ ﺣﯿﻦ أن ﻗﯿﻤﺔ  IC50ﻟﻠﺪواء اﻟﻘﯿﺎﺳﻲ ) ﻋﻘﺎر دوﻛﺴﻮروﺑﯿﺴﯿﻦ(
 25.88ﻣﯿﻜﺮوﻏﺮام  /ﻣﻞ .اﺳﺘﻨﺎدا إﻟﻰ ھﺬه اﻟﻨﺘﺎﺋﺞ ،ﻓﮭﻨﺎك ﺣﺎﺟﺔ اﻟﻰ إﺟﺮاء دراﺳﺔ ﻟﻌﺰل اﻟﻤﺮﻛﺐ اﻟﻤﻀﺎد
ﻟﻠﺴﺮطﺎن ﻓﻲ ﻣﺴﺘﺨﻠﺺ ﺟﺬور ﻧﺒﺎت اﻟﻤﻮرﯾﻨﺠﺎ اﻟﺬاﺋﺐ ﻓﻲ ﻣﺴﺘﺨﻠﺺ اﻟﻜﻠﻮروﻓﻮرم.

اﻟﻜﻠﻤﺎت اﻟﻤﻔﺘﺎﺣﯿﺔ :اﻟﻤﻨﺘﺠﺎت اﻟﻄﺒﯿﻌﯿﺔ ،ﻧﺒﺎت اﻟﻤﻮرﯾﻨﻐﺎ ،اﻟﺘﺤﻠﯿﻞ اﻟﻜﯿﻤﯿﺎﺋﻲ اﻟﻨﺒﺎﺗﻲ ، GC-MS ،ﻓﺎﻋﻠﯿﺔ ﻣﻀﺎدات
اﻟﺴﺮطﺎن ،ﺳﺮطﺎن اﻟﺜﺪي.
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Chapter 1: Introduction
1.1 Overview
Cancer is a generic term that can affect any part of the body by the quick
formation of irregular cells that grow beyond its normal boundaries and which can then
affect adjoining parts of the body later that leads to death (WHO, 2018). Globally,
cancer is the second leading cause of human death and about 1 in 6 deaths is due to
cancer and an estimated 9.6 million deaths in 2018 (WHO, 2018). Most of the cancer
causing deaths (70%) occurs in middle and low income countries. In 2018, an
estimated 18.1 million new cases and 9.6 million cancer deaths were reported. Lung
cancer is listed as the highest diagnosed cancer (11.6%) and the prominent cause of
death (18.4%), followed by female 11.6% of breast cancer, 7.1% of prostate cancer
and 6.1% of colorectal cancer (Bray et al.,2018). Most of the cancer causing deaths is
due to tobacco and alcohol use, low intake of vegetable and fruits, high body mass
index and lack of physical activity. Worldwide, about 2.1 million newly diagnosed
female breast cancer cases reported in 2018. This cancer types is the most commonly
diagnosed cancer in the majority of the nations accounting for 1 in 4 cancer cases
among women (Bray et al., 2018). Similarly, the cancer burden in United Arab
Emirates was ranked the second foremost cause of non-communicable diseases related
mortality in the country (WHO, 2014; Loney et al., 2013).
Globally, UAE become one of the fastest growing economies (Shihab et al.,
2001) with this growth leading to economic, sociodemographic, and lifestyle changes,
paralleled by an epidemiological increase in the rates of non-communicable diseases.
Among women in Arab countries, Breast cancer is the most common (El Saghir et al.,
2007). According to WHO report, 22.4% of new cases of breast cancer were diagnosed

2
with an associated mortality rate of 12.4% were reported in 2018 (WHO, 2018). Breast
cancer is associated with three immunohistochemical biomarkers such as progesterone
receptor, human epidermal growth factor 2 and Estrogen Receptor (McAnena et al.,
2018). The four molecular subtypes [luminal A (ER/PR +ve, HER2 -ve), luminal B
(ER and/or PR +ve, HER2 +ve), HER2 over-expressing (HER2 +ve alone) and triple
negative (-ve for all 3 receptors)] of breast cancer are defined by the presence or
absence of above mentioned receptors (Network, 2012). Each subtype shows separate
rate of recurrence, prognoses and varied treatment strategies (Sørlie et al., 2001). The
primary treatment option for breast cancer is to remove the entire tumor. However, this
treatment of is no longer possible if it spread to other parts of the body. Now a day,
there are number of treatment options viz., chemotherapy, hormone therapy, targeted
therapies and radiotherapy etc. In most cases, the treatments can be combined or
various treatments are used one after other. Depends on response of tumors the
treatment approach can be varied. However, these treatment options having some
undesirable side effects such as hair loss, muscle and joint problems, lower bone
density, sleep problems, damages healthy body cells, mouth sores, nausea and
indigestion, dry skin and dry mucous membranes, anemia, susceptibility to infections,
fatigue, nausea, vomiting, diarrhea, heart issues and tiredness etc. (IQWiG, 2006).
Hence, the innovation and development of new anticancer molecules from nature have
been focused (Wright, 2017; Yao et al., 2017).
1.2 Plant based drugs
Plants have long held a prominent place as a source of new drugs, accounts of
their use dating as far back as 4000 BC (Nickell, 1959). The WHO states that about
three-quarters of the world peoples trusts upon traditional therapies (mainly herbs) for
their primary health care. In fact, herbs/plants are the oldest friends of mankind. They
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not only provided shelter and food but also helped the humanity to treat many diseases.
Most of plant derived drugs were discovered by the study of traditional and folk
knowledge and some of these could not be replaced despite the enormous advancement
in synthetic chemistry (Gilani and Rahman, 2005). Complex and varied natural
products have yielded many active lead molecules for the discovery of new medicines.
Naturally derived molecules have exhibited tremendous biological activities
including anticancer activity (Huang et al., 2019). As a key source of drugs, naturally
derived molecules play a significant role in the discovery of new drugs. More than
60% of antitumor medicines are closely associated to natural products. The anticancer
activity of natural molecules often act by inducing autophagy or apoptosis, or
inhibiting cell proliferation and regulating immune function (Rayan et al., 2017).
Besides, in clinical treatment, the abnormal activity of tyrosine kinase has become an
vital target since it is the main cause of tumors. However, natural products are guiding
the discovery of new tyrosine kinase inhibitors with its molecular structure diversity
and unique mode of action. Development of new anticancer drugs with tyrosine kinase
inhibitory potential from natural source will bring new advances anticancer drugs
development (Yin et al., 2019). Plant derived molecules such as alkaloids, terpenoids,
flavonoids, saponins, polysaccharides and other molecules have been reported as
natural bioactive molecules with potent anticancer activity (Avato et al., 2017; Joshi et
al., 2017; Majumder et al., 2017).
The United Arab Emirates has a rich tradition of herbal medicine and
numerous traditional systems of medicine were used for the health care treatment. In
addition to plant based medicines, other treatments such as cupping, bone settings
and cauterization are also practiced, in which particular foods and medicinal plants
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are used as part of the treatment (Ghazanfar, 1994). The country is home to around
731 vascular plant species and has the fourth largest number of angiosperm plants in
Arabian Peninsula and about 260 plants are used for medicinal practices (Sakkir et
al., 2012).
1.3 Genus Moringa and its importance
The genus Moringa is the sole representative of the family Moringaceae and
the distribution of this extends across continents. The species also cultivated in
different parts of world especially in Asia and Africa for variety of applications. The
genus Moringa is utilized for its multiple uses. Historical evidence indicated that
different civilizations viz., Egyptian, Indian and Greek were using Moringa for several
purposes for thousands of years. To maintain their mental fitness and skin health, they
desired to have the fruits and the leaves of Moringa in their daily diet. Moreover, the
juice gives added energy to the soldiers in the war field. The leaf extracts of Moringa
were given to the ancient Maurian warriors as it was believed that the decoction
discharges them from the stress and pain earned during the war (Jahn, 1986; Manzoor
et al., 2007; Fuglie, 2001). The civilizations of ancient Egyptian, Greek and Roman
were highly valued the Ben oil (Edible oil) from Moringa seeds for making perfume
and protecting their skin. The Egyptians used the ben oil since the middle and old
kingdoms (3000-2000 BC) (Miller and Morris, 1988; ICUN, 2005). Fahey (2005)
reports that the seeds of this plant species are used in water purification, the leaves are
source of very important nutrients, the oil is used as biofuel, the trunks produce gum,
the flowers produce honey and all plant parts can be used for various medicinal
purposes. The real potentials of Moringa species should be capitalized for the great
benefit to the rural people in many parts of the world who depend mostly on
indigenous plants for their livelihoods. More efforts are needed in this regard so that
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these valuable species will properly be noticed and received the attention which the
plants rightfully deserve (Padayachee and Baijnath, 2012). There are 13 species under
this genus which includes M. arborea, M. borziana, M. concanensis, M. drouhardii,
M. hildebrandtii, M. longituba, M. oleifera, M. ovalifolia, M. peregrine, M. pygmaea,
M. rivae, M. ruspoliana and M. stenopetala (TFLI, 2014). Though there are enormous
reports on different parts of few species from the genus Moringa, it is still the genus
the species of which have not been explored completely. The Moringa species have
attained broad research interest because of their excellent economic potential (Arora et
al., 2013). Among the different species under Moringa, current investigation is focused
to Moringa peregrina. The other species are being studied and explored minimally for
naturally occurring bioactive constituents (Rani et al., 2018).
1.4 Relevant Literature
Moringa peregrina and its pharmacological potential
This plant originated in Arabian Peninsula (Bellostas et al., 2010) and well
adapted to extreme climate conditions (Robiansyah et al., 2014). This plant is a fastest
growing tree (Abd El-Wahab, 1995) with the height of 3-10 m (Bellostas et al., 2010).
M. peregrina is generally distributed in Saudi Arabia (Migahid, 1978) Baluchestan,
Iran (Ghahreman, 2001), Yemen, Somalia, (Somali et al., 1984), Oman (Al-Owaisi et
al., 2014) and in Jordan (Al-Dabbas et al., 2010). Around 5000 years ago, the healing
potential of Moringa was documented in the Indian Vedic litrature (Patwardhan,
2000). The plant has many medicinal values both in folk and traditional medicine
(Miller and Morris, 1988; Ghazanfar and Al-Al-Sabahi. 1993; Al-khatani, 1995;
Reddy et al., 2015). In traditional and folk medicine, the young leaves are used as
antioxidant and wound healing and the juice of bark is used as a disinfectant (Marwah
et al., 2007). The bark juice also used to treat headache, fever, back and muscle pains,
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slimness, constipation, labor pain and burns (Boulos, 2000; Elbatran et al., 2005;
Tahany et al., 2010). The convulsions or infantile paralysis is treated by pod oil (Miller
and Morris, 1988). In folk medicine, the leaf extract is rubbed over skin for the
treatment of skin rashes and paralysis (Ghazanfar and Al-Al-Sabahi, 1993). Seeds of
M. peregrina are used very commonly to control diabetes (Al-Kahtani, 1995; Reddy et
al., 2015). The seeds also used for the treatment of symptoms related to diabetes viz.,
hyperglycemia and hyperlipidemia. Seeds of the plant are used for treatment of
abdominal pain (Van der Vossen and Mkamilo, 2007). For wound healing purpose, the
leaves are used (Nawash and Al- Horani, 2011). The roots and leaves of M. peregrina
are used to treat stomach disorders, malaria, asthma, hypertension, to expel a retained
placenta and diabetes (Mekonnen et al., 1999). Also, the oil of the plant is used to treat
scabies, itches and freckles, (Al-Dhaheri, 2016). Scientifically, the M. peregrina plant
parts such as leaves, roots and flowers were studied for many pharmacological
activities such as anti-diabetic, anticancer, antimicrobial, hypertension, antiinflammatory, antioxidant, anti-spasmodic, hepatotoxicity, memory disorders and
lipid lowering activity and also, the plant has yielded some active molecules.
Recently, Senthilkumar et al. (2018) extensively reviewed traditional uses, biological
activity and phytochemistry of M. peregrina.
1.4.1 Anti-spasmodic
Sadraei et al. (2015) was studied anti-spasmodic effect of leaves and seeds M.
peregrina by ileum contractions. Both the leaves and seed extracts had inhibitory
effect on ileum contractions induced by acetylcholine, electrical field stimulation, and
KCl. The seed extract had more potential with the IC50 values of 230 (electrical field
stimulation), 118 (acetylcholine) and 18 (KCL) μg/ml. Whereas, The leaf extract
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showed inhibitory potential of ileum contraction with the IC50 values of 314 (electrical
field stimulation), 365 (acetylcholine) and 439 (KCL) μg/ml.
1.4.2 Anti-diabetic
Different M. peregrina extracts were studied for its hypoglycemic properties.
Hydroalcoholic extract of seeds of M. peregrina was studied for antidiabetic
potential against streptozotocin induced diabetic rats (El-Haddad et al., 2002). The
level of blood glucose was decreased by the fractions of chloroform and petroleum
ether. Elbatran et al. (2005) investigated the antidiabetic potential of ethanolic extract
of M. peregrina. The levels of aspartate aminotransferase, serum glucose and alanine
aminotransferase were decreased significantly by the extract.

The authors also

observed that the low density lipoprotein, cholesterol and serum triglycerides were
decreased through the administration of M. peregrina extract. The ethanol and
aqueous seed extracts of M. peregrina were investigated for their anti- diabetic
activity (Koheil et al., 2013). The level of blood glucose was reduced when the rats
treated with a dose of 150 mg/kg body weight. The administration of M. peregrina
aqueous ethanolic extracts reduces the values of reduced glutathione and nitric oxide
values close to the normal level. The authors also observed the low levels of
enzymatic antioxidants such as superoxide dismutase, catalase and glutathione
peroxidase. Hydro-alcoholic extract of M. peregrina dried leaves inhibited the
enzymes viz. dipeptidyl peptidase IV, α-amylase and α-glucosidase and (Ullah et al.,
2015). The pancreatic α-amylase inhibitory potential of M. peregrina showed that the
enzyme responded to the extract depended on concentration. Also, in a dose dependent
manner, the extract inhibited the mammalian DPP IV enzyme.
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1.4.3 Anti-inflammatory
Previously, ethanol and aqueous extracts from M. peregrina were
investigated for anti-inflammatory (Koheil et al., 2011). The study was conducted
using inflammation in rats induced by fresh egg albumin. Both the extracts were
reduced the acute inflammation significantly. 72.96 and 81.01% of inflammation were
reduced by the aqueous and ethanol extracts respectively at a dose of 300 mg/kg.
Whereas, the control drug reduced 100% of the inflammation at the dose of 100
mg/kg.
1.4.4 Antioxidant
The antioxidant effect of aqueous and ethanol extracts M. peregrina was
studied by Marwah et al. (2007). Both the extracts showed good antioxidant effect
with the IC50 value of 7.6 µg/ml. Aqueous and ethanol extracts of seeds of M.
peregrina were investigated for antioxidant activity Koheil et al. (2011). Both the
extracts were studied for different antioxidant potentials viz., DPPH free radical
scavenging ability, superoxide anion scavenging activity, chelating effect of ferrous
ions, hydroxyl radical scavenging potential, reducing power and hydrogen peroxide
scavenging potential and the results were compared with the control. The highest
antioxidant activity was recorded in ethanol extract at 6 mg/ml concentration. At the
same concentration, free radical scavenging potential of the aqueous extract was nearly
equal to trolox. Further, the results on superoxide anion scavenging potential indicated
that both the extracts displayed worthy superoxide anion scavenging activity than
BHA. The results on chelating potential indicated that the activity dose depended
manner and the inhibition were 60% and 37% for ethanol and aqueous extracts
respectively. At a concentration of 1.0 mg/ml, the chelating potential of extract of
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ethanol was closely equal to the standard, EDTA. The hydroxyl radical scavenging
activity was same at 20 and 40 µg/ml concentration for both the extracts. However, the
ethanol extract exhibited hydroxyl radical scavenging activity than the control,
ascorbic acid. At a concentration of 100 μg/ml, 65% and 79% of hydrogen peroxide
radicals were scavenged by aqueous and ethanol extracts respectively. While, the
control BHT, BHA and α-tocopherol scavenged 28, 35 and 75% respectively. Both
the extracts exposed similar reducing power potential comparable to that of control, αtocopherol.
Dehshahri et al. (2012) studied the antioxidant activity of different extracts of
leaves of M. peregrina. All the extracts showed significant H2O2 activity. The M.
peregrina extracts showed good DPPH free radical scavenging activity with the EC50
values of 4.4 μg/mL (Moustafa et al., 2014). Ullah et al. (2015) studied the ABTS•+
radical scavenging activity of M. peregrina hydro-alcoholic extract and the extract
showed dose dependent activity with an IC50 value of 20.56 μg/mL. El-Awady et al.
(2016) reported the antioxidant activity of methanol and aqueous extracts of M.
peregrina. The highest DPPH scavenging potential (165.49 mg ascorbic acid
equivalent) was observed in methanol extract. The seed oil of M. peregrina showed
good DPPH scavenging activity at 172 mMol Trolox equivalent/kg (Elabd et al.,
2017). Young M. peregrina leaf extract exhibited DPPH free radical inhibition of
74.78% (Juhaimi et al., 2017).
1.4.5 Antimicrobial
Previously, M. peregrina were investigated for its antibacterial, antiviral and
antifungal potential. The ethanol extract of M. peregrina were investigated for antihepatitis B viral potential HepG2.2.15 cells (Mehdi et al., 1997). Further, M.
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peregrina hydro-alcoholic extract showed the antiviral activity against herpes
simplex-1 virus (Soltan and Zaki, 2009). However, the extract was found to be
inactive against vesicular stomatitis and poliomyelitis-1 viruses.
M. peregrina seed oil was studied for antimicrobial activity against
Escherichia coli, Enterobacter cloacae, Staphylococcus epidermidis, Pseudomonas
aeruginosa, Klebsiella pneumonia, Staphylococcus aureus, Candida glabrata, C.
albicans and C. tropicalis (Lalas et al., 2012). The authors compared the activity
with the standard antibiotics. The oil showed good anti-microbial activity against all
the microorganisms and C. glabrata was detected as a most resistant strain to the
extract. Ethanol extract of M. peregrina leaves, seed coat and endosperm was studied
for antimicrobial activity against various strains of bacteria and fungus (Hajar and
Gumgumjee, 2014). The M. peregrina leaf extract displayed notable antibacterial
activity. The antibacterial activity of ethanol and methanol leaf extracts of M.
oleifera and M. peregrina was compared. Both the plant extracts showed good
antibacterial potential against Aeromonas hydrophila, P. aeruginosa, Enterococcus
sps, E. coli and S. aureus. However, M. peregrina has less activity compared to M.
oleifera (El-Awady et al., 2015). Majali et al. (2015) studied the ethanol extract of M.
peregrina seeds, leaves and roots for antibacterial activity against Klebsiella
pneumonia, E. coli and S. aureus. Among the samples, the root extract had good
antibacterial potential with the zone of inhibition of 44‒59 mm (K. pneumonia), 18‒
42 mm (E. coli) and 34‒ 45 mm (S. aureus). The activity was in order of root extract
followed by leaf ethanol extract and seed extract.
Different bacterial strains Viz. E. coli ATCC 29522 and O157:H7, S. aureus,
K. oxytoca, Proteus mirabilis, Proteus vulgaris, MRSA, Klebsiella pneumonia,
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Salmonella paratyphi, Enterobacter aerogenes, Salmonella typhimurium and
Pseudomonas aeruginosa were used to study the antibacterial ability of acetone,
ethanol, methanol and aqueous extracts of both field grown samples and in vitro
plantlets of M. peregrina (Alrayes et al., 2016). The results indicated that the in vitro
plantlets displayed good antibacterial activity. The seed aqueous extract of M.
peregrina was screened for antibacterial activity against multidrug resistant
Salmonella species. The extract showed good activity with a minimum inhibitory
concentration ranged between 109.37 and 437.5 mg/mL (Saleh et al., 2017).
1.4.6 Hypertension
The M. peregrina hydroalcoholic extract was investigated on oxidative status
and blood pressure in hypertensive rats induced with dexamethasone. body weight,
thymus weight, antioxidant power, concentration of plasma hydrogen peroxide and
systolic blood pressure were measured to find out the effect (Safaeian et al., 2015).
The authors reported that 400 mg/kg dose level of M. peregrina extract prevents the
rise of blood pressure. While, the reversal study showed that the extract failed to lower
the SBP in in rats. It has no effect on the thymus weight loss and failed to prevent the
changes in body weight. But, the other report revealed the M. peregrina seed extract
decreased the weight of the body and the administration of 200 and 400 mg/kg dose
prevented the rise of concentration of H2O2 (Rouhi-Broujeni et al., 2013). The reduced
antioxidant power was observed in the rats administrated with 400 mg/kg of M.
peregrina extract (Safaeian et al., 2015). So, the availability of antioxidant molecules
in M. peregrina plays an important role in antihypertensive activity.
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1.4.7 Hepatotoxicity
Seed oil M. peregrina with the dose of 150 mg/kg reduced the damage of
mice liver in doxorubicin induced liver damage (Sliai and Abdel-Rahman, 2016).
The results indicated that the reduction in apoptotic index and caspase-3
immunoreactivity of mice treated with seed oil of M. peregrina. The oil also
investigated along with other species of Moringa for oxidative stress state of liver
tissue in liver damage treated with high fat diet (Elabd et al., 2017). The authors
analysed the marker enzymes such as total serum cholesterol, glucose, lipid
peroxidation,

high-density

lipoprotein

cholesterol,

low-density

lipoprotein

cholesterol, triacylglycerol and antioxidant enzymes after the treatment. The results
showed the increased total serum cholesterol, alanine transaminase, glucose,
aspartate transaminase and body weight in high fat diet fed rats. The seed oil also
improved the content of glucose, liver enzymes and lipid profile significantly. M.
peregrina ethanol leaf extract reduced the activities of serum hepatic marker
enzymes (Azim et al., 2017). The authors noted that the antioxidant enzymes were
reduced in acetaminophen intoxicated rats. Whereas, the enhanced activities of
glutathione peroxidase, superoxide dismutase and catalase were noted in the rats
administrated with the leaf extract of M. peregrina.
1.4.8 Anti-cancer
In earlier studies, seed oil of M. peregrina was reported for anticancer
activity on different cell lines viz. colon cancer, liver cancer, mouse fibroblasts,
cervical cancer and breast cancer cell lines (Elsayed et al., 2016). The results
revealed that the oil showed significant anticancer activity against all the cell lines
tested. The IC50 values of the oil was 850.9, 604.3, 935.8, 721.7 and 366.3 µg/mL for

13
colon cancer, liver cancer, mouse fibroblasts, cervical cancer and breast cancer cell
lines respectively.
However, the root tubers of M. peregrina were not studied before, as
formation of root tubers is the unique feature of M. peregrina during the seedling
phase (Munyanziza and Yongabi, 2007). Therefore, the preset work was aimed to
study the phytochemical analysis and anticancer activity of M. peregrina tuber
extracts with the following objectives.
•

To collect the root tubers of M. peregrina

•

To prepare the crude extracts from the root tubers using different organic
solvents viz., hexane, chloroform, acetone and methanol.

•

To analyze the phytochemical compositions of the crude extracts by GC-MS.

•

To study the anticancer activity of the extracts on human breast cancer cell
line (MCF-7).
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Chapter 2: Materials and Methods
2.1 Plant materials
The root tubers of Moringa peregrina were collected from six months older
plants from Al Foah Experimental Farm [24°21’31.139’’N 55°47’57.239” E (Altitude
303 M)], Al Ain, UAE. The collected samples were again washed then the root tubers
were made into small pieces using cutter and shade dried in the laboratory. The dried
samples were again dried in hot air oven (50ºC) and powdered in a grinding mill. The
powdered plant samples were stored in airtight containers for the preparation of crude
extracts (Figure 1).

Figure 1: Root tubers of M. peregrina and processing and extraction of crude extracts
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2.2 Preparation of crude extracts
The crude extracts were prepared using a Soxhlet apparatus with increasing
polarities of organic solvents viz., hexane, chloroform, acetone and methanol. The extracts
were combined, dried stored at +4°C for GC-MS analysis and anticancer activity.
2.3 Gas chromatogram and GC- Mass Spectrometry analysis
GC (Gas chromatogram) was done using Gas Chromatography (Agilent
Technologies) which was equipped with automatic liquid sampler and mass selective
detector. The chromatograph was built-in with HP 5 MS capillary column (30 m×250
µm i.d., film thickness 0.25 µm). The injector temperature was kept at 250ºC and the
oven temperature was begin with 70ºC and programmed to 450ºC (10ºC/min) and
finished 300ºC for 9 mts. The plant sample was diluted with acetone (1:10) and one
microlitre of sample was in the split mode in the rate of 1:100. Helium was used as
carrier gas and the flow rate was 1.5 ml/min. The % of each chemical compound of
the plant extract was calculated by GC peaks areas without any correction factors.
GC-mass spectrometry (GC-MS) was achieved using the same chromatography fitted
with mass spectrometer. Same GC conditions were adopted and the same column
(HP 5 MS) was used. Ion source and transfer line temperature was kept at 240ºC and
mass spectra were obtained by centroid scan of the mass range between 40 and 700
amu. Retention time (RT), retention indices (RI), mass spectra of NIST and WILEY
library data of the GC-MS were compared to identify each chemical compound.
2.4 Anti-cancer activity of crude extracts
2.4.1 Cell culture and cell viability Assay
Human breast cancer cell line (MCF-7) was purchased from European
Collection of Animal Cell Cultures. Cells were cultured in the Eagle's minimal
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essential medium supplemented with 10% heat-inactivated fetal bovine serum and
1% penicillin-streptomycin. The cultures were maintained at 37°C in a humidified
atmosphere with 5% CO2 in the incubator. After the cells grown in the 75mm flask,
trypsinised and transferred into the new flask. Continue the process for couple of
passages until the cells become healthy. Cells were collected from the 70% confluent
flask, placed in 96-well culture plates at a density of 2 × 104 cells/well and incubated
at 37°C for 24 h. After incubation, cells were treated with different concentrations of
the extracts viz. 10, 20, 40, 80, 160 and 380 µg/ml. The stock solution of extracts was
prepared in dimethyl sulfoxide (DMSO) and stored at −20°C until use. These cells
were further incubated for 72 h, after which the cell viability was measured using the
WST-1

(4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,

3-benzene

disulfonate) (Abcam, Cambridge, USA) colorimetric assay. After the addition of
10ul of wst-1 reagent into each well, cells were incubated at 37oC for 4 hours. Each
96 well plate was kept in a Shaker for one minute with gentle shaking and the plate
were measured the absorbance of color changes at 450 nm wavelength in the
microplate reader (Thermo Scientific Multiscan GO, Waltham, MA USA).
Doxorubicin was used as a standard. The growth inhibition percentage was
calculated using the formula Inhibition % = (OD of Control – OD of sample)/OD of
Control) x 100. The IC50 values were calculated through dose-response curves for
each cell line.
2.5 Statistical evaluation
IC50 values for anticancer tests were derived from a nonlinear regression
analysis (curve fit) based on sigmoid dose response curve (variable) and computed
using Graph Pad Prism 6 (Graph pad, SanDiego, CA, USA). Calculated the standard
deviation of the result.
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Chapter 3: Results
In the present study, the chemical composition and anticancer activity of
hexane, chloroform, acetone and methanol extracts of root tubers of M. peregrina
were studied. The chemical composition of four different extracts was analyzed by
Gas Chromatography, Mass Spectrometry and the gas chromatograph of each
extracts are given in Figures 2-5, and list of chemical compounds are presented in
Table Nos. 1-4. Anticancer activity of the extracts was performed on human breast
cancer cell line (MCF-7) and the results are presented in Figures 6-9 and Table 5.
3.1 Chemical composition of different solvent extracts of M. peregrina root
tubers
The results on chemical composition of hexane extract of M. peregrina root
tubers are presented in Table 1 and gas chromatogram is given in Figure 2. A total of
33 compounds were identified and the major compounds was β -Sitosterol (16.90%)
followed by Stigmasterol (12.36%), 24-methyl- 5-Cholestene-3-ol (11.83%), cis-10Heptadecenoic acid (10.85%), n-Hexadecanoic acid (8.95%), cis-Vaccenic acid
(8.5%), Methyl cis, cis-9,12-octadecadienoate (5.20%), 8-Octadecenoic acid methyl
ester (5.09%), 4-methyl-methyl ester Pentadecanoic acid (4.66%), (3β)- 9,19Cyclolanostan-3-ol, 24-methylene (1.91%), Oleic Acid (1.70%) and 9-Octadecenoic
acid (Z) Methyl ester (1.46%). Other compounds such as Methyl stearate (0.96%), 4methoxy- 1H-Benzotriazole (0.93%), (Z,Z)- 9,12-Octadecadienoyl chloride (0.86%),
(E)- 9-Octadecen-1-ol (0.84%), Docosanoic acid methyl ester (0.78%), Methyl 18methylnonadecanoate (0.73%), 9-Phenyl-5H-benzocycloheptene (0.70%), 1H-STriazolo [1,5-a]pyridin-4-ium, 2-hydroxy-1-methyl-, hydroxide (0.69%), α-Amyrin
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Figure 2: Gas chromatogram of hexane extract of M. peregrina root tubers
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Table 1: Chemical compositions of hexane extract of M. peregrina root tubers
Peak
No.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24

Retention time
(RT)
16.467
16.681
16.913
17.074
17.395
17.561
17.871
18.210
18.513
18.578
18.626
18.804
19.030
19.084
19.220
19.363
19.423
20.326
20.552
20.980
22.164
23.400
23.662
24.578

25
26
27
28
29
30
31
32
33

25.803
26.207
26.302
27.146
27.360
27.919
27.979
28.246
29.198

Name of the Compounds
Cyclotetradecane
methyl ester (Z)9-Hexadecenoic acid
4-methyl-methyl ester Pentadecanoic acid
cis-9-Hexadecenoic acid
n-Hexadecanoic acid
Octadecanoic acid
15-methyl-, methyl ester Hexadecanoic acid
(E)- 9-Octadecen-1-ol
Methyl cis,cis-9,12-octadecadienoate
8-Octadecenoic acid methyl ester
9-Octadecenoic acid (Z) Methyl ester
Methyl stearate
cis-10-Heptadecenoic acid
cis-Vaccenic acid
Oleic Acid
Estra-1,3,5(10)-trien-17β-ol
(Z)- 9,17-Octadecadienal
4-methyl- Cyclopentadecanone
Methyl 18-methylnonadecanoate
Eicosanoic acid methyl ester
Docosanoic acid methyl ester
(Z,Z)- 9,12-Octadecadienoyl chloride
Tetracosanoic acid methyl ester
1H-S-Triazolo[1,5-a]pyridin-4-ium, 2-hydroxy1-methyl-, hydroxide
4-methoxy- 1H-Benzotriazole
1-Heptacosanol
Arsenous acid, tris(trimethylsilyl) ester
24-methyl- 5-Cholestene-3-ol
Stigmasterol
β-Sitosterol
α-Amyrin
9-Phenyl-5H-benzocycloheptene
(3β)- 9,19-Cyclolanostan-3-ol, 24-methylene
Total

Percentage
0.23
0.29
4.66
0.48
8.95
0.13
0.52
0.84
5.20
5.09
1.46
0.96
10.85
8.50
1.70
0.35
0.22
0.30
0.73
0.13
0.78
0.86
0.43
0.69
0.93
0.23
0.22
11.83
12.36
16.90
0.57
0.70
1.91
100
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(0.57%), 15-methyl-, methyl ester Hexadecanoic acid (0.52%), cis-9-Hexadecenoic acid
(0.48%), Tetracosanoic acid methyl ester (0.43%), Estra-1,3,5(10)-trien-17β-ol (0.35%),
4-methyl- Cyclopentadecanone (0.30%), methyl ester (Z)9-Hexadecenoic acid (0.29%),
Cyclotetradecane (0.23%), 1-Heptacosanol (0.23%), (Z)- 9,17-Octadecadienal (0.22%),
Arsenous acid, tris(trimethylsilyl) ester (0.22%), Octadecanoic acid (0.13%) and
Eicosanoic acid methyl ester (0.13%) were identified as minor compounds.
The GC-MS analyses revealed that the chloroform extract of M. peregrina tubers
contains fifty compounds and the results are presented in Figure 3 and Table 2. In
chloroform extract, Hexylene glycol (36.35%) and 4,5-Diaminobenzofurazan (12.59%)
were identified as the major compounds. 5.81% of N-(phenylmethyl)- Acetamide, 5.5%
of 3-methyl- Butanamide, 5.13% of Tetradecanoic acid, 3.72% of N-Benzylformamide,
3.18% of 9-Hexacosene, 2.38% of 1-(phenylmethyl)- 3-Pyrrolidinone and 2.27% of (Z)13-Octadecenal were also identified as prominent chemical compounds. Whereas, 4,5dimethyl-2-phenyl- 1,3-Dioxolane (1.82%), (Z)-9,17-Octadecadienal (1.64%), 2hydroxy-1-methylpropyl esterStearic acid (1.55%), 1-phenyl- 1,2-Ethanediol (1.42%),
2,2,2-trifluoro-N-(phenylmethyl)- Acetamide (1.37%), N-Benzylbenzamide (1.26%), Z7-Hexadecenoic acid (0.98%), β-oxo-4-phenyl-1-Piperazinepropanenitrile (0.95%), αMethylbenzylamine (0.88%), Benzyl alcohol (0.81%), Hexadecanoic acid ethyl ester
(0.80%), (isothiocyanatomethyl)- Benzene (0.79%), Isopropyl palmitate (0.65%), 7ethyl-2-methyl-4-Undecanone
Nitrosoanilino]
(0.43%),

thioacet

(0.59%),

amide

1,1,2,3,3-pentachloro-

2-Methoxydiftalone

(0.52%),
Propane

(0.54%),

α-

[N-

1-methyl-5,7-Indolinedicarboxaldehyde
(0.37%),

octadecadienoate (0.37%), 1-benzyl-2,2,3,3-tetram

Methyl

10-trans,

12-cis-
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Figure 3: Gas chromatogram of chloroform extract of M. peregrina root tubers
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Table 2: Chemical compositions of chloroform extract of M. peregrina root tubers
Peak
No.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37

Retention time
(RT)
5.360
6.984
6.984
8.167
8.434
8.827
9.380
9.528
10.016
10.093
10.498
10.973
11.348
11.449
11.788
12.044
12.317
12.442
12.930
13.726
14.172
14.529
14.755
15.046
15.124
15.278
15.718
16.325
16.896
17.068
17.282
17.496
17.561
17.621
17.841
17.972
18.245

38
39
40
41
42
43
44
45
46
47
48
49
50

18.870
18.923
19.161
19.357
19.411
19.476
20.332
20.963
21.105
21.730
22.729
23.192
25.969

Name of the Compounds
Benzyl alcohol
1,1,2,3,3-pentachloro- Propane
Methyl 10-trans, 12-cis-octadecadienoate
Hexylene glycol
3-methyl- Butanamide
1-(phenylmethyl)- 3-Pyrrolidinone
1-benzyl-2,2,3,3-tetram Azetidine
4,5-dimethyl-2-phenyl- 1,3-Dioxolane
N-(1,1-dimethylethyl)- Benzamide
1-phenyl- 1,2-Ethanediol
(isothiocyanatomethyl)- Benzene
N-Benzylformamide
4-hydroxy- Benzeneethanol
N-(phenylmethyl)- Acetamide
Tetradecamethy l- Cycloheptasiloxane
4,5-Diaminobenzofurazan
2,4-bis(1,1-dimethylethyl) Phenol
N-Carbamoylmethyl-N-phenylacetamid
1,4-dihydro-1-methyl-4-oxo-3-Pyridinecarbonitrile
N-methyl-β,3, 4-tris(trimethylsiloxy)- Phenethylamine
2,2,2-trifluoro-N-(phenylmethyl)- Acetamide
1-methyl-5,7-Indolinedicarboxaldehyde
N-(phenylmethyl)- 1,2-Ethanediamine
1-Benzylamino-6-benzyloxyhexane
N-hydroxy-N-(p henylmethyl)-Benzenemethanamine
1-(4-butylpheny)- Pyrrole-2,5-dione
7-ethyl-2-methyl-4-Undecanone
β-oxo-4-phenyl-1-Piperazinepropanenitrile
14-methyl-Pentadecanoic acid methyl ester
Palmitoleic acid
Tetradecanoic acid
2-(1,1-dimethylethyl)-6-methyl-1,3-Dioxan-4-one
Hexadecanoic acid ethyl ester
α-[N-Nitrosoanilino]thioacet amide
Isopropyl palmitate
N-Benzylbenzamide
N,N'-Nonamethylenebis[-S-3-aminopropyl thiosulfuric
acid]
Z-7-Hexadecenoic acid
9-Hexacosene
(Z)-13-Octadecenal
cis-11,14-Eicosadienoic acid methyl ester
2-Methyl-Z,Z-3,13-octadecadienol
Benzylammoniotris(trifluoromethyl) borinate
2-hydroxy-1-methylpropyl esterStearic acid
α-Methylbenzylamine
2-Methoxydiftalone
(Z)-9,17-Octadecadienal
5-[4-Methoxyphenoxy]-6-amino-8-methoxyquinaldine
2,2'-dithiobis[5-nitro-Pyridine
Tris(tert-butyldimethylsilyloxy)arsane
Total

Percentage
0.81
0.37
0.37
36.35
5.50
2.38
0.37
1.82
0.12
1.42
0.79
3.72
0.30
5.81
0.27
12.59
0.30
0.20
0.15
0.12
1.37
0.43
0.14
0.19
0.14
0.12
0.59
0.95
0.29
0.23
5.13
0.31
0.80
0.52
0.65
1.26
0.36
0.98
3.18
2.27
0.26
0.30
0.36
1.55
0.88
0.54
1.64
0.28
0.34
0.18
100
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Azetidine (0.37%), N,N'-Nonamethylenebis[-S-3-aminopropyl thiosulfuric acid]
(0.36%), Benzylammoniotris(trifluoromethyl) borinate (0.36%), 2'-dithiobis[5-nitroPyridine (0.34%), 2-(1,1-dimethylethyl)-6-methyl-1,3-Dioxan-4-one (0.31%), 4hydroxy- Benzeneethanol (0.3%), 2,4-bis(1,1-dimethylethyl) Phenol (0.3%), 2Methyl-Z,Z-3,13-octadecadienol (0.3%), 14-methyl-Pentadecanoic acid methyl ester
(0.29%),

5-[4-Methoxyphenoxy]-6-amino-8-methoxyquinaldine

(0.28%),

Tetradecamethy l- Cycloheptasiloxane (0.27%), cis-11,14-Eicosadienoic acid methyl
ester (0.26%), Palmitoleic acid (0.23%), N-Carbamoylmethyl-N-phenylacetamid (0.2%),
1-Benzylamino-6-benzyloxyhexane

(0.19%),

Tris(tert-butyldimethylsilyloxy)arsane

(0.18%), 1,4-dihydro-1-methyl-4-oxo-3-Pyridinecarbonitrile (0.15%), N-(pheny- lmethyl)- 1,2-Ethanediamine (0.14%), N-hydroxy-N-(p henylmethyl)-Benzene- methanamine (0.14%), N-(1,1-dimethylethyl)- Benzamide (0.12%), N-methyl-b,3, 4tris(trimethylsiloxy)- Phenethylamine (0.12%) and 1-(4-butylpheny)- Pyrrole-2,5-dione
(0.12%) were identified as the minor compounds in chloroform extract of M. peregrina
root tubers.
The gas chromatogram of acetone extract of M. peregrina root tubers
is given in Figure 4 and the chemical compounds are listed in Table 3. As shown in
table, GC-MS analysis of the extract resulted in the identification of ten compounds
representing 100% of the extract. The major compounds were 3-methyl-3-butenyl)Benzene (24.95%), 1-Benzylazetidine (18.24%), cis-13-Octadecenoic acid (15.89%),
followed by 1-benzyltetrahydroisoquinoline (11.04%), 2,4,6-Cycloheptatrien -1-one,
3,5-b is-trimethylsilyl (6.52%), 1-methyl- 4-Piperidinemethanol (5.86%),
Octadecadien-1-ol (5.56%),

E,Z-2,13-

1,1,1,3,5,5,5-Heptamethyltrisiloxane (4.67%), E-10-

Pentadecenol (4.02%), (3-methyl-3-butenyl)-Benzene (3.25%).
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Figure 4: Gas chromatogram of acetone extract of M. peregrina root tubers
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Table 3: Chemical compositions of acetone extract of M. peregrina root tubers
Peak
No.
1
2
3
4
5
6
7
8
9
10

Retention time
(RT)
7.150
8.755
12.317
17.252
18.204
18.911
21.736
27.295
27.818
31.035

Name of the Compounds
Benzyl nitrile
3-methyl-3-butenyl)- Benzene
1-Benzylazetidine
E,Z-2,13-Octadecadien-1-ol
E-10-Pentadecenol
cis-13-Octadecenoic acid
1-methyl- 4-Piperidinemethanol
1,1,1,3,5,5,5-Heptamethyltrisiloxane
1-benzyltetrahydroisoquinoline
2,4,6-Cycloheptatrien-1-one, 3,5-b istrimethylsilyl
Total

Percentage
18.24
24.95
3.25
5.56
4.02
15.89
5.86
4.67
11.04
6.52
100

The results on the chemical composition analysis of methanol extract of M.
peregrina root tubers are given in Figure 5 and Table 4. Totally, 24 compounds were
identified and 4-hydroxy- Benzeneacetonitrile was identified as a major compound
among the compounds representing about 12.09% of the total extract. Moreover, lValine, N-benzyloxycarbonyl-decyl ester (9.96%), Phenyl cyanide (9.8%), Benzoic
acid (9.13%), 2-Benzyloxyethyl chloroformate (7.03%), Benzeneacetamide (6.55%),
2,4-dihydroxy-Benzaldehyde (6.48%), 4-Benzylamino-1-methylcytosine (5.86%), cis13-Octadecenoic acid (4.77%), Benzeneacetic acid (4.56%), 2,2,6,6-tetramethyl-4Piperidinone (4.39%), 2,4-Dimethyl-2,4-pentanediol (2.82%), N-(phenylmethylene)Benzenemethanamine (2.55%), (E)-2-Butenoic acid, 2-methylpropyl ester (2.47%),
Benzyl isopropenyl ether (1.72%), 5-Hydroxymethylfurfural (1.39%), 1-(phenylmethyl)- dl-Proline (1.2%), Benzenemethanethiol (1.17%), (Z,Z)-9,12-Octadecadienoic
acid (1.16%), 3-Amino-4-methylbenzamide

(1.12%), 2-Hydroxyethyl methacrylate

(1.08%), Z-11- Hexadecenoic acid (1.01%), 4-[(phenylmethyl)amino]-Phenol (0.93%)
and Cyclopentadecane (0.76%) were also identified in methanol extract of M. peregrina
root tuber.
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3.2 Anticancer activity of different solvent extracts of M. peregrina root tubers
Anticancer potential of various solvent extracts of M. peregrina root tubers on

human breast cancer cell line (MCF-7) are presented in Table 5 and Figures 6 & 7.
The activity was compared with the standard drug Doxorubicin and results revealed
that all the four extracts were inhibited the breast cancer cells at the maximum
concentration of 320 µg/ml. The highest activity was noted in chloroform extract
with the inhibition percentage of 37.28, 48.53, 63.45, 72.14, 87.02 and 93.76 for 10,

Figure 5: Gas chromatogram of methanol extract of M. peregrina root tubers
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Table 4: Chemical compositions of methanol extract of M. peregrina root tubers
Peak
No.
1
2
3
4
5
6
7
8
9
10
11

Retention time
(RT)
6.770
7.126
7.834
8.256
8.518
8.797
8.910
10.474
10.896
11.092
11.437

12
13
14

11.972
14.624
15.118

15
16
17
18
19
20
21
22
23

15.677
17.068
17.163
17.276
17.395
18.073
18.870
18.929
21.795
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24.881

Name of the Compounds
2,2,6,6-tetramethyl-4-Piperidinone
Phenyl cyanide
Benzoic acid
2,4-Dimethyl-2,4-pentanediol
5-Hydroxymethylfurfural
Benzyl isopropenyl ether
Benzeneacetic acid
1-(phenylmethyl)- dl-Proline
Benzeneacetamide
3-Amino-4-methylbenzamide
(E)-2-Butenoic acid, 2-methylpropyl
ester
4-hydroxy- Benzeneacetonitrile
4-[(phenylmethyl)amino]-Phenol
N-(phenylmethylene)Benzenemethanamine
2-Hydroxyethyl methacrylate
Z-11- Hexadecenoic acid
Benzenemethanethiol
2-Benzyloxyethyl chloroformate
4-Benzylamino-1-methylcytosine
Cyclopentadecane
(Z,Z)-9,12-Octadecadienoic acid
cis-13-Octadecenoic acid
l-Valine, N-benzyloxycarbonyl-decyl
ester
2,4-dihydroxy-Benzaldehyde
Total

Percentage
4.39
9.80
9.13
2.82
1.39
1.72
4.56
1.20
6.55
1.12
2.47
12.09
0.93
2.55
1.08
1.01
1.17
7.03
5.86
0.76
1.16
4.77
9.96
6.48
100
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Table 5: Anticancer activity of various solvent extracts of M. peregrina root tubers
on human breast cancer cell line (MCF-7)
Name of the
extract/Compound
Hexane Extract

Chloroform Extract

Acetone Extract

Methanol Extract

Doxorubicin

Control

Concentration
(µg/ml)

% of
inhibition

10
20
40
80
160
320
10
20
40
80
160
320
10
20
40
80
160
320
10
20
40
80
160
320

6.78 ±0.07
11.92±0.83
17.46±0.84
25.03±0.97
33.11±0.89
51.03±0.53
15.1±0.22
23.15±1.39
30.51±1.64
41.89±3.11
60.14±3.96
85.01±2.01
5.93±0.08
9.44±1.18
19.04±1.96
23.55±1.55
39.83±2.07
56.93±3.18
3.54±0.27
10.63±0.08
15.09±0.81
22.05±1.96
27.56±1.04
38.45±0.75

3.125
6.25
12.5
25
50
100
0

9.453±0.15
21.934±1.46
38.675±0.88
49.734±1.47
63.352±1.95
85.056±2.56
0

IC50
(µg/ml)

315.0

127.38

284.5

353.10

25.88

-
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Figure 6: Cell viability of human breast cancer cell line (MCF-7) treated with various
extracts of M. peregrina root tubers and standard drug. ‘a-b’- Hexane extract; ‘c-d’ –
Chloroform extract; ‘e-f’- Acetone extract; ‘g-h’-Methanol extract; ‘i-j’- Standard
drug, Doxorubicin; ‘k-l’ – control.
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Figure 7: Graphical representation of cell viability of human breast cancer cell line
(MCF-7) with various extracts of M. peregrina root tubers and doxorubicin. A
Hexane extract; B – Chloroform extract; C- Acetone extract; D-Methanol extract; EStandard drug, Doxorubicin.
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Figure 7: Graphical representation of cell viability of human breast cancer cell line
(MCF-7) with various extracts of M. peregrina root tubers and doxorubicin. A
Hexane extract; B – Chloroform extract; C- Acetone extract; D-Methanol extract; EStandard drug, Doxorubicin (cont’d).
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Figure 7: Graphical representation of cell viability of human breast cancer cell line
(MCF-7) with various extracts of M. peregrina root tubers and doxorubicin. A
Hexane extract; B – Chloroform extract; C- Acetone extract; D-Methanol extract; EStandard drug, Doxorubicin (cont’d).
20, 40, 80, 160 and 320 µg/ml concentrations respectively. The IC50 values for
chloroform extract of root tubers was 127.38 µg/ml. While, the acetone extract
showed moderate activity with the IC50 values of 284.5 µg/ml with the inhibition
percentage of 5.93, 9.44, 19.04, 23.55, 39.83 and 56.93 for the tested concentrations.
The hexane and methanol extracts of M. peregrina showed moderate activity against
the cell lines tested. The hexane extract showed 51.03% of cell inhibition at the
maximum concentration of 320 µg/ml. The methanol extract showed less activity
when compared to other extracts texted with the inhibition percentage of 38.45 at the
maximum concentration tested. The IC50 values of hexane and methanol extracts M.
peregrina root tubers were 315.0 and 353.10 µg/ml respectively. Whereas, the
standard Doxorubicin inhibited 85.056% of cells at the maximum concentration of
100 µg/ml and the IC50 value was 25.88 µg/ml. There was no inhibition observed
control experiment.
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Chapter 4: Discussion
Phytochemicals from plants have become key sources in discovery and
development of new drugs. For the last few decades, natural molecules especially the
one having anticancer potential gained great attention. It has been studied for
potential anticancer activity and low toxicity in normal cells (Newman and Cragg,
2016; Tesfaye and Ravichadran, 2018). The pharmacological activity of plants
extracts is mainly resulted from the mixture of compounds. Hence, it is essential to
quantify the preliminary phytochemical composition to relate the biological potential
and it will help to investigate the presence of particular class of phytochemicals. To
best of my knowledge, there was no previous study on phytochemical analysis and
pharmacological potential of root tubers of M. peregrina. However, the leaves of M.
peregrina were reported for preliminary phytochemical screening. The hydro
alcoholic extract of M. peregrina leaves were screened for phytochemical compound
analysis (Ullah et al., 2015). The results showed the presence of different
concentrations of phenolics, tannins, alkaloids, and saponins. These phytochemicals
are plays vital role in biological activities (Ramawat et al., 2009). In the present study,

β-Sitosterol was identified as the major compound (16.90%) in hexane extract of M.
peregrina root tubers. β-Sitosterol is one of subcomponents of a group phytosterols
found in all plants (Rakel, 2018). Stigmasterol also found as a major compound in the
hexane extract (12.36%). The presence of these two compounds was already identified
in the leaf methanol extract of Pongamia pinnata by GC-MS (Sangwan, 2019). βsitosterol also deducted in whole plant extracts of Leptadenia reticulata and Pluchea
lanceolata (Mallick and Dighe, 2014). The authors High Performance Thin Layer
Chromatography to estimate the compound.
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50 compounds were identified in chloroform extract of M. peregrina root
tubers. When compared to other extracts, the numbers of compounds were high in
this extract. It is based on the solubility of phytochemicals in solvent as well as the
elusion in GC column. Hexylene glycol was identified as the major compound
(36.35%) by GC-MS. 4,5-Diaminobenzofurazan also occupied 12.59% of total
extract. Al-Owaisi et al. (2014) reported the phytochemical composition of various
solvent extracts viz. (hexane, chloroform, ethyl acetate and methanol) of leaves of M.
peregrina. The authors identified a total of 32 compounds and 1-cyclohexyl ethanone
occupied 27.26% followed by 17.11% of pentacosane, 16.57% of hexacosane,
15.45% of tetracosane, 13.02% of heptacosane, 11.79% of tricosane, 9.10% of
octacosane, 8.08% of cyclopentanol and 7.36%1-methyl and 2-heptanone, 3-methyl.
However, 4,5-Diaminobenzofurazan not reported previously in M. peregirna plant
extracts.
In acetone extract of M. peregrina, only ten compounds were identified by
GC-MS. Among that 3-methyl-3-butenyl - Benzene was the predominant molecule
with highest percentage (24.95%). But this compound not reported previously in M.
peregrina and also in other plant species.

In the meantime, one of the major

compounds in acetone extract of M. peregrina root tubers, HexamethylCyclotrisiloxane was reported in many plants. GC-MS analysis of Solanum villosum
leaves revealed that the presence of Hexamethyl-Cyclotrisiloxane with 2.12%
(Venkatesh et al., 2014). The presence of this compound in leaf ethyl acetate extract
of Acacia karoo (Priyanka et al., 2015). Babu et al. (2017) reported the presence of
Hexamethyl-Cyclotrisiloxane in Ficus arnottiana leaf chloroform extract. The
compound also studied for its biological activity. the authors reported no activity.
Hexamethyl cyclotrisiloxane also identified in leaf and stem extracts of Bauhinia
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acuminate (Krishna et al., 2015) and essential oils of Sedum pallidum (Dahpour et
al., 2012).
Previously, leaves, bark, and seeds of M. peregrina were reported for its
phytochemical analysis. The dried leaves of M. peregrina were reported for the
quantification of total phenol content (Safaeian et al., 2015). Aqueous and methanol
extracts of leaves were investigated for phenol and flavonoid contents (El-Awady et
al., 2016; Azim et al., 2017)). Also, Marwah et al. (2007) and Elabd et al. (2017)
reported the phenol content of bark and seed oils. The occurrence of oleic acid-3
hydroxy propyl ester was reported in oily aqueous seed extract of M. peregrina (Saleh
et al., 2017). However, the root tubers were studied for phytochemical analysis for the
first time. The GC-MS analyses of methanol extract of root tubers M. peregrina
showed that the presence of 24 compounds account about cent percent of the extract.
The major chemical composition of the extract was 4-hydroxy- Benzeneacetonitrile
with the percentage of 12.09. This compound was not deducted in M. peregrina plant
parts in earlier studies. However, 4-hydroxy- Benzeneacetonitrile was reported in
Moringa oleifera extracts. Mathur and Kamal (2012) studied the phytochemical
composition of pods of Moringa oleifera by GC-MS and authors deducted 3.16% of 4hydroxy- Benzeneacetonitrile. Vats and Gupta (2017) deducted very less amount
(0.24%) of 4-hydroxy- Benzeneacetonitrile in hydroethanolic extract of Moringa
oleifera. Hence, the results on phytochemical screening on the present study indicated
that the availability of phytochemicals is based on different factors such as the
geographical location, maturity of plants, solvents used for the extraction etc.
Plant derived molecules are prosperous sustainable resources for new drugs
with chemical and biological significance. In earlier studies, various chemical
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compounds analysed by GC-MS were studied for its pharmacological activities
(Kumar et al., 2010; Sermakkani and Thangapandian, 2012; Ezhilan and
Neelamegam, 2012; Kumar et al., 2014; Ravisankar and Ester, 2017). In the present
study, hexane, chloroform, acetone and methanol extracts of M. peregrina root tubes
were screened for anticancer activity against human breast cancer cell line (MCF-7).
The cell line was treated with different concentrations viz. 10,20,40,80,160 and 320
µg/ml plant extracts and the results were compared with the standard drug
Doxorubicin. All the four extracts were inhibited the breast cancer cells at the
maximum concentration of 320 µg/ml. However, the highest activity was noted in
chloroform extract. This result is in accordance with previous studies.
Al-Oqail et al. (2015) reported the anticancer activity of chloroform extract
of Nepeta deflersiana along with various sub fractions of the plant against human
breast cancer (MCF-7) and human lung cancer cell lines (A-549). It was found that
the chloroform extract and its sub fraction reduced the cell viability of the both the
cells significantly in a concentration dependent manner. Dried leaf chloroform
extract of Rinum amabile were reported for the ant proliferative effect on different
cell lines viz. breast carcinoma with estrogen receptor (MCF-7), breast carcinoma
without estrogen receptor (MDA-MB-23), colon adenocarcinoma (HT-29), acute
lymphoma leukemia (Reh) and colon carcinoma (HCT-16) (Lim et al., 2019).The
authors reported that the chloroform extract showed concentration depended
cytotoxic effect on all the cell lines tested. Similarly, chloroform extract of
Polygonatum verticillatum rhizomes was investigated for the anticancer activity
against MCF-7 cell lines with different concentrations ranging from 25 to 400 μg/mL
and the extract showed good anticancer activity (Singh and Patra, 2018). In the
present study, the activity of chloroform extract of M. peregrina root tubers may be
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associated with the chemical compounds which dissolved in non-polar solvent such
as chloroform. Furthermore, it is believed that the synergistic effect of phytochemical
present in the extract is responsible for the biological activity.
In 2011, Shang et al. reported the anticancer activity of Taxus cuspidate
extracts and its synergistic effect with 5-FU. The experiment was performed on
breast, lung, gastric, prostate, melanoma, hepatocellular, oral squamous, cervical,
leukemic, mouse spleen T and B lymphocytes, human embryonic lung and normal
cell lines. The synergistic effect study showed it was effective in cancer cell line and
had lower cytotoxicity in normal human cell. A study was executed to find the
synergetic anticancer potential of Berberine and Curcumin on human cancer cell
lines MCF-7, Hep-G2, A549, K562 and Jurkat. The estimation of inhibition of the
cell proliferation showed that synergetic anticancer potential of Berberine combained
with Curcumin showed greater cell death percentage compared to pure compounds
tested. There is no evidence of the hexylene glycol have the anti-cancerous
properties, present major percentage in the chloroform extract, but the benzofurazan,
the next highest percentage compound are reported with anti-cancerous properties.
The presence of ethylene glycol may be synergized the cytotoxic effect of
benzofurazan on cancer cells.

Chloroform extract showed highest anti cancer

activities and GC-MS analysis showed traces of different compounds in the extract.
The acetone and methanol extracts of M. peregrina root tubers showed less anticancer
activity even though the acetone extracts contain benzylisoquinoline alkaloid as the
major compound. This structurally diverse group metabolite is long history of study
and it has already exploited for its medicinal properties. However, ecophysiological
functions of many benzylisoquinoline alkaloids are unknown (Hagel and Facchini,
2013).
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Chapter 5: Conclusion
Natural products are the ideal candidates for the discovery and development of
novel drugs. Nowadays, plant derived compounds gained attention to have significant
importance in the treatment of a wide range of diseases including cancers. It is due to
the efficiency, lesser/no side effects, easy availability and cost-effectivity.
Phytochemicals such as tannins, flavonoids and Polyphenolic compounds showed
anticancer activity on different cell lines through various mechanisms. In the present
study, hexane, chloroform, acetone and methanol extracts of M. peregrina were
screened for phytochemical analysis and anticancer activity. Phytochemical analysis
was performed by Gas Chromatography and Mass spectrometry (GC-MS). The
anticancer potential of the extracts was done on the human breast cancer cell line
(MCF-7) and cell viability was measured using WST-1 Cell Proliferation Assay Kit.
The cell line was treated with different concentrations (10, 20, 40, 80, 160 and 320
µg/ml) of plant extracts and the results were compared with the standard drug
Doxorubicin. The results of GC-MS analysis of hexane extract revealed that a total of
33 compounds were identified and the major compounds was β-Sitosterol (16.90%),
Stigmasterol (12.36%), 24-methyl- 5-Cholestene-3-ol (11.83%), cis-10-Heptadecenoic
acid (10.85%), n-Hexadecanoic acid (8.95%), cis-Vaccenic acid (8.5%), Methyl cis, cis9,12-octadecadienoate (5.20%), 8-Octadecenoic acid methyl ester (5.09%), 4-methylmethyl ester Pentadecanoic acid (4.66%), (3β)- 9,19-Cyclolanostan-3-ol, 24-methylene
(1.91%), Oleic Acid (1.70%) and 9-Octadecenoic acid (Z) Methyl ester (1.46%).
Chloroform extract of M. peregrina tubers contains fifty compounds among that
Hexylene glycol (36.35%) and 4,5-Diaminobenzofurazan (12.59%) N-(phenylmethyl)Acetamide (5.81%), 3-methyl- Butanamide (5.5%), Tetradecanoic acid (5.13%), N-
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Benzylformamide (3.72%), 9-Hexacosene (3.18%), 1-(phenyl-methyl)- 3-Pyrrolidinone
(2.38%) and (Z)-13-Octadecenal (2.27%) were identified as prominent chemical
compounds. In acetone extract, 3-methyl-3-butenyl)- Benzene (24.95%), 1Benzylazetidine (18.24%), cis-13-Octadecenoic acid (15.89%), followed by 1benzyltetrahydroisoquinoline

(11.04%),

2,4,6-Cycloheptatrien-1-one,

trimethylsilyl (6.52%), 1-methyl- 4-Piperidinemethanol (5.86%),

3,5-b

is-

E,Z-2,13-Octa-

decadien-1-ol (5.56%). In methanol extract, 4-hydroxy- Benzeneacetonitrile was
identified as a major compound among the compounds representing about 12.09% of the
total extract. Moreover, l-Valine, N-benzyloxycarbonyl-decyl ester (9.96%), Phenyl
cyanide (9.8%), Benzoic acid (9.13%), 2-Benzyloxyethyl chloroformate (7.03%),
Benzeneacetamide (6.55%), 2,4-dihydroxy-Benzaldehyde (6.48%), 4-Benzylamino-1methylcytosine (5.86%), cis-13-Octadecenoic acid (4.77%), Benzeneacetic acid
(4.56%),

2,2,6,6-tetramethyl-4-Piperidinone

(4.39%)

also

identified

as

major

compounds. The anticancer activity revealed that the chloroform extract of M.
peregrina showed good activity against the human breast cancer cell line with the IC50
value of 127.38 µg/ml. The IC50 values of hexane, acetone and methanol extracts were
315.0, 284.8 and 353.10 µg/ml respectively. Whereas the IC50 value of the standard
drug, Doxorubicin was 25.88 µg/ml. The present study shows that the chloroform
extract of M. peregrina root tubers showed good anticancer activity and it could be
used further for the isolation and characterization of new anticancer molecules. Since
the naturally derived molecules are having high efficacy and low drug resistance and
easily biodegradable.
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